Agios Pharmaceuticals, Inc. (AGIO)
33.32
-0.96
(-2.80%)
USD |
NASDAQ |
Aug 28, 16:00
33.32
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Cash and Short Term Investments (Quarterly) : 617.58M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 617.58M |
| March 31, 2026 | 737.04M |
| December 31, 2025 | 854.42M |
| September 30, 2025 | 952.86M |
| June 30, 2025 | 938.94M |
| March 31, 2025 | 893.38M |
| December 31, 2024 | 893.71M |
| September 30, 2024 | 1.005B |
| June 30, 2024 | 569.89M |
| March 31, 2024 | 597.99M |
| December 31, 2023 | 776.93M |
| September 30, 2023 | 647.49M |
| June 30, 2023 | 702.57M |
| March 31, 2023 | 739.20M |
| December 31, 2022 | 783.12M |
| September 30, 2022 | 727.68M |
| June 30, 2022 | 819.31M |
| March 31, 2022 | 923.53M |
| December 31, 2021 | 1.020B |
| September 30, 2021 | 1.266B |
| June 30, 2021 | 1.673B |
| March 31, 2021 | 2.336B |
| December 31, 2020 | 572.93M |
| September 30, 2020 | 605.54M |
| June 30, 2020 | 790.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 528.62M |
| December 31, 2019 | 564.88M |
| September 30, 2019 | 451.90M |
| June 30, 2019 | 495.39M |
| March 31, 2019 | 524.56M |
| December 31, 2018 | 585.30M |
| September 30, 2018 | 669.89M |
| June 30, 2018 | 716.90M |
| March 31, 2018 | 782.45M |
| December 31, 2017 | 423.94M |
| September 30, 2017 | 507.93M |
| June 30, 2017 | 586.04M |
| March 31, 2017 | 479.76M |
| December 31, 2016 | 541.31M |
| September 30, 2016 | 579.10M |
| June 30, 2016 | 465.37M |
| March 31, 2016 | 312.89M |
| December 31, 2015 | 317.00M |
| September 30, 2015 | 352.36M |
| June 30, 2015 | 369.79M |
| March 31, 2015 | 344.71M |
| December 31, 2014 | 342.06M |
| September 30, 2014 | 219.97M |
| June 30, 2014 | 238.48M |
| March 31, 2014 | 162.27M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Biogen, Inc. | 1.285B |
| Insmed, Inc. | 1.160B |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Exelixis, Inc. | 839.38M |